The Science Board will hear about: (1) The Center for Biologics Evaluation and Research’s strategic goals for regulatory science;  (2) a progress update on FDA’s Opioid Action Plan and the Bovine  Heparin Initiative; (3) a response from the Office of Scientific Professional Development to the Science Board’s report on the Commissioner’s Fellowship  Program;  (4) a report from the Scientific Engagements Subcommittee; and (5) a report from the  Food Emergency Response Network Cooperative Agreement Program Evaluation  Subcommittee.

Federal Register Announcement